Pfizer Inc.
PFE
Xếp hạng trong cổ phiếu
#119
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Giá cổ phiếu
$29.55
Đồng bộ lần cuối: 2026-10-16
Vốn hóa thị trường
$168.40B
Thay đổi (1 ngày)
0.37%
Thay đổi (1 năm)
20.54%
Quốc gia
US
Giao dịch Pfizer Inc. (PFE)
Danh mục
Healthcare
EPS của Pfizer Inc. (PFE)
EPS tính đến June 2026 TTM: $0.76
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Pfizer Inc., EPS hiện tại của công ty (TTM) là $0.76. Vào cuối năm 2024, công ty có EPS là $1.42, tăng so với EPS năm 2023 là $0.38.
Lịch sử EPS của Pfizer Inc. từ 2000 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.76 | -44.12% |
| 2025 | $1.36 | -4.23% |
| 2024 | $1.42 | 278.16% |
| 2023 | $0.38 | -93.29% |
| 2022 | $5.59 | 41.45% |
| 2021 | $3.95 | 139.80% |
| 2020 | $1.65 | -43.57% |
| 2019 | $2.92 | 53.85% |
| 2018 | $1.90 | -46.78% |
| 2017 | $3.57 | 202.42% |
| 2016 | $1.18 | 4.63% |
| 2015 | $1.13 | -21.17% |
| 2014 | $1.43 | -16.31% |
| 2013 | $1.71 | 29.99% |
| 2012 | $1.32 | 18.09% |
| 2011 | $1.11 | 8.12% |
| 2010 | $1.03 | -16.26% |
| 2009 | $1.23 | 3.15% |
| 2008 | $1.19 | 0.51% |
| 2007 | $1.19 | -21.95% |
| 2006 | $1.52 | 47.57% |
| 2005 | $1.03 | -31.79% |
| 2004 | $1.51 | 179.63% |
| 2003 | $0.54 | -63.51% |
| 2002 | $1.48 | 18.40% |
| 2001 | $1.25 | 108.33% |
| 2000 | $0.60 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| $29.89 | 3,832.89% |
US
|
|
| $6.60 | 768.42% |
US
|
|
| $3.55 | 367.11% |
US
|
|
| $20.39 | 2,582.76% |
CH
|
|
| $1.26 | 65.79% |
US
|
